Deinove (XPAR:ALDEI) Days Payable : 99.35 (As of Jun. 2022)

View and export this data going back to 2010. Start your Free Trial

What is Deinove Days Payable?

Deinove's average Accounts Payable for the six months ended in Jun. 2022 was €1.13 Mil. Deinove's Cost of Goods Sold for the six months ended in Jun. 2022 was €2.08 Mil. Hence, Deinove's Days Payable for the six months ended in Jun. 2022 was 99.35.

The historical rank and industry rank for Deinove's Days Payable or its related term are showing as below:

XPAR:ALDEI's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 148.53
* Ranked among companies with meaningful Days Payable only.

Deinove's Days Payable declined from Jun. 2021 (156.70) to Jun. 2022 (99.35). It may suggest that Deinove accelerated paying its suppliers.

Deinove Days Payable Historical Data

The historical data trend for Deinove's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deinove Days Payable Chart

Deinove Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Days Payable

Get a 7-Day Free Trial

98.99

109.08

85.98

167.26

147.49

Deinove Semi-Annual Data
	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
Days Payable	Get a 7-Day Free Trial															144.50	380.12	156.70	139.76	99.35

Competitive Comparison of Deinove's Days Payable

For the Biotechnology subindustry, Deinove's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Deinove's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Deinove's Days Payable distribution charts can be found below:

* The bar in red indicates where Deinove's Days Payable falls into.

Deinove Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Deinove's Days Payable for the fiscal year that ended in Dec. 2021 is calculated as

	Days Payable (A: Dec. 2021 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2020 )	+	Accounts Payable (A: Dec. 2021 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2021 )	*	Days in Period
=	( (1.695	+	1.283)	/	2 )	/	3.685	*	365
=	1.489					/	3.685	*	365
=	147.49

Deinove's Days Payable for the quarter that ended in Jun. 2022 is calculated as:

	Days Payable (Q: Jun. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2021 )	+	Accounts Payable (Q: Jun. 2022 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2022 )	*	Days in Period
=	( (1.283	+	0.986)	/	2 )	/	2.084	*	365 / 2
=	1.1345					/	2.084	*	365 / 2
=	99.35

Deinove Days Payable Related Terms

Thank you for viewing the detailed overview of Deinove's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Deinove (XPAR:ALDEI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Deinove SA (XPAR:ALDEI) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

1682 rue de la Valsiere, Cap Sigma, ZAC Euromedecine II, Grabels, FRA, 34790

Website

http://www.deinove.com

Deinove SA is a biotechnology company engaged in the development of technologies and molecules for the health, nutrition and cosmetics industries. It is developing in two areas of activity, New-generation anti-infective ANTIBIOTICS which involves the search for novel anti-infective molecules and the development of new generations of drugs capable of responding to the challenges of antibiotic resistance; and BIOACTIVES, natural active ingredients discovers, develops and produces bioactives, active ingredients of natural origin from its bacterial biodiversity bank, to invent the new generation of sustainable cosmetics and intends to quickly bring its know-how and its products to other fields, such as nutrition and health.

Deinove (XPAR:ALDEI) Headlines

No Headlines